BRACANAT 150MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹4060.29

NATCO PHARMA LTD (ONCOLOGY DIV): Bracanat 150MG Tablet, 30 tablets, salt olaparib 150mg. NPPA has revised its MRP from Rs 7,453.12 to Rs 4,060.29 (46% lower) with effect from 09-11-2026; trade rate Rs 3,093.55. Group: PARP inhibitor (targeted therapy). Same salt is also supplied by Abbott, AstraZeneca, Cipla, Dr. Reddy's, Emcure and others. Handling/counselling: tablet and capsule forms are not interchangeable mg for mg; check the prescription carefully. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.